Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program

At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially un...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Blood Ročník 114; číslo 2; s. 299
Hlavní autori: Hoogenkamp, Maarten, Lichtinger, Monika, Krysinska, Hanna, Lancrin, Christophe, Clarke, Deborah, Williamson, Andrew, Mazzarella, Luca, Ingram, Richard, Jorgensen, Helle, Fisher, Amanda, Tenen, Daniel G, Kouskoff, Valerie, Lacaud, Georges, Bonifer, Constanze
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 09.07.2009
Predmet:
ISSN:1528-0020, 1528-0020
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene colony-stimulating-factor 1 receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodeling is mediated by the transient binding of RUNX1 to Pu.1 cis-elements. By contrast, chromatin reorganization of Csf1r requires prior expression of PU.1 together with RUNX1 binding. Once the full hematopoietic program is established, stable transcription factor complexes and active chromatin can be maintained without RUNX1. Our experiments therefore demonstrate how individual transcription factors function in a differentiation stage-specific manner to differentially affect the initiation versus maintenance of a developmental program.
AbstractList At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene colony-stimulating-factor 1 receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodeling is mediated by the transient binding of RUNX1 to Pu.1 cis-elements. By contrast, chromatin reorganization of Csf1r requires prior expression of PU.1 together with RUNX1 binding. Once the full hematopoietic program is established, stable transcription factor complexes and active chromatin can be maintained without RUNX1. Our experiments therefore demonstrate how individual transcription factors function in a differentiation stage-specific manner to differentially affect the initiation versus maintenance of a developmental program.At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene colony-stimulating-factor 1 receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodeling is mediated by the transient binding of RUNX1 to Pu.1 cis-elements. By contrast, chromatin reorganization of Csf1r requires prior expression of PU.1 together with RUNX1 binding. Once the full hematopoietic program is established, stable transcription factor complexes and active chromatin can be maintained without RUNX1. Our experiments therefore demonstrate how individual transcription factors function in a differentiation stage-specific manner to differentially affect the initiation versus maintenance of a developmental program.
At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene colony-stimulating-factor 1 receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodeling is mediated by the transient binding of RUNX1 to Pu.1 cis-elements. By contrast, chromatin reorganization of Csf1r requires prior expression of PU.1 together with RUNX1 binding. Once the full hematopoietic program is established, stable transcription factor complexes and active chromatin can be maintained without RUNX1. Our experiments therefore demonstrate how individual transcription factors function in a differentiation stage-specific manner to differentially affect the initiation versus maintenance of a developmental program.
Author Mazzarella, Luca
Bonifer, Constanze
Lichtinger, Monika
Williamson, Andrew
Tenen, Daniel G
Krysinska, Hanna
Jorgensen, Helle
Fisher, Amanda
Clarke, Deborah
Ingram, Richard
Kouskoff, Valerie
Hoogenkamp, Maarten
Lacaud, Georges
Lancrin, Christophe
Author_xml – sequence: 1
  givenname: Maarten
  surname: Hoogenkamp
  fullname: Hoogenkamp, Maarten
  organization: Leeds Institute for Molecular Medicine, University of Leeds, Leeds, United Kingdom
– sequence: 2
  givenname: Monika
  surname: Lichtinger
  fullname: Lichtinger, Monika
– sequence: 3
  givenname: Hanna
  surname: Krysinska
  fullname: Krysinska, Hanna
– sequence: 4
  givenname: Christophe
  surname: Lancrin
  fullname: Lancrin, Christophe
– sequence: 5
  givenname: Deborah
  surname: Clarke
  fullname: Clarke, Deborah
– sequence: 6
  givenname: Andrew
  surname: Williamson
  fullname: Williamson, Andrew
– sequence: 7
  givenname: Luca
  surname: Mazzarella
  fullname: Mazzarella, Luca
– sequence: 8
  givenname: Richard
  surname: Ingram
  fullname: Ingram, Richard
– sequence: 9
  givenname: Helle
  surname: Jorgensen
  fullname: Jorgensen, Helle
– sequence: 10
  givenname: Amanda
  surname: Fisher
  fullname: Fisher, Amanda
– sequence: 11
  givenname: Daniel G
  surname: Tenen
  fullname: Tenen, Daniel G
– sequence: 12
  givenname: Valerie
  surname: Kouskoff
  fullname: Kouskoff, Valerie
– sequence: 13
  givenname: Georges
  surname: Lacaud
  fullname: Lacaud, Georges
– sequence: 14
  givenname: Constanze
  surname: Bonifer
  fullname: Bonifer, Constanze
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19339695$$D View this record in MEDLINE/PubMed
BookMark eNpNkM1KLDEQhYMo_r-BSFbu-pqf7nTiTkS9F0RBFNwN6aQyE0knbdItzkv5jPagwl1VFXznnKo6QNsxRUDohJI_lEp23oWUbMUIkRWlFVVUKrKF9mnDZEUII9v_9XvooJRXQmjNWbOL9qjiXAnV7KPPa53DGptVTr0efcRTdClYH5e4W-PH5_sXeoE17lMAMwWdMXwMQccZTRG7lLH1zkGGOHodcIa3yWfo57FgO-WNTRnAeOfNt-QdcpkK7rWPI0QdDeDk8LgCvIJ5gTQkD6M3eAkRNlkZStnohpyWWfdHaMfpUOD4px6i55vrp6u_1d3D7b-ry7vKNE07VqJWWnWEd4yLRltVE6WlajtGpRVSWNu2tSGcOCGV41ISLbkzquVC1FbXgh2is2_fOfdtgjIuel8MhPl0SFNZiLYWglE1g6c_4NT1YBdD9r3O68Xvh9kXwCeFVQ
CitedBy_id crossref_primary_10_1182_blood_2010_11_316893
crossref_primary_10_1038_nature25022
crossref_primary_10_1038_leu_2010_104
crossref_primary_10_1182_blood_2014_04_572958
crossref_primary_10_1016_j_exphem_2017_01_003
crossref_primary_10_1182_blood_2009_05_222307
crossref_primary_10_1002_jcp_24462
crossref_primary_10_1017_S1462399410001377
crossref_primary_10_1080_17474086_2022_2108015
crossref_primary_10_2492_inflammregen_34_224
crossref_primary_10_1182_blood_2013_01_480244
crossref_primary_10_1016_j_bcmd_2023_102745
crossref_primary_10_1056_NEJMra1003733
crossref_primary_10_1016_j_devcel_2016_01_024
crossref_primary_10_1186_s12867_017_0087_y
crossref_primary_10_1182_blood_2009_04_216903
crossref_primary_10_1007_s12185_015_1762_8
crossref_primary_10_1073_pnas_2019655118
crossref_primary_10_1111_j_1600_065X_2010_00964_x
crossref_primary_10_1182_blood_2011_10_386094
crossref_primary_10_4049_jimmunol_1003703
crossref_primary_10_1186_s13072_019_0282_9
crossref_primary_10_1101_gad_176826_111
crossref_primary_10_1182_blood_2009_07_235176
crossref_primary_10_1182_blood_2014_01_550855
crossref_primary_10_1242_dev_115709
crossref_primary_10_1242_dev_094961
crossref_primary_10_1016_j_it_2014_03_001
crossref_primary_10_1016_j_leukres_2014_04_013
crossref_primary_10_1038_onc_2011_32
crossref_primary_10_1182_blood_2012_08_451641
crossref_primary_10_1111_imr_12215
crossref_primary_10_1080_10428194_2017_1410882
crossref_primary_10_1128_MCB_00175_18
crossref_primary_10_1186_s13072_022_00444_9
crossref_primary_10_1182_blood_2010_08_302976
crossref_primary_10_1038_nrg3207
crossref_primary_10_3390_ijms20020350
crossref_primary_10_1002_jcb_25723
crossref_primary_10_1146_annurev_physiol_021119_034352
crossref_primary_10_1016_j_gde_2013_07_003
crossref_primary_10_1016_j_ydbio_2016_04_004
crossref_primary_10_1016_j_cell_2018_05_048
crossref_primary_10_1038_nm_2122
crossref_primary_10_1016_j_exphem_2011_07_005
crossref_primary_10_1182_blood_2009_08_240556
crossref_primary_10_3816_CLML_2010_n_013
crossref_primary_10_1038_emboj_2012_275
crossref_primary_10_1182_blood_2011_12_397091
crossref_primary_10_3390_cells12182303
crossref_primary_10_1007_s00018_015_1871_9
crossref_primary_10_1016_j_bpj_2021_04_002
crossref_primary_10_1016_j_bcmd_2010_02_009
crossref_primary_10_1016_j_ydbio_2012_03_024
crossref_primary_10_3389_fimmu_2014_00156
crossref_primary_10_1016_j_margen_2019_01_003
crossref_primary_10_1097_MOH_0000000000000628
crossref_primary_10_1074_jbc_RA119_010149
crossref_primary_10_1093_nar_gkx573
crossref_primary_10_1111_imr_12206
crossref_primary_10_1182_blood_2016_12_689109
crossref_primary_10_3389_fcell_2024_1510198
crossref_primary_10_1186_s13072_025_00621_6
crossref_primary_10_1038_onc_2012_274
crossref_primary_10_1016_j_exphem_2018_04_008
crossref_primary_10_1002_wsbm_1163
crossref_primary_10_1242_dev_148296
crossref_primary_10_1038_ncomms8203
crossref_primary_10_1080_15384101_2016_1203491
crossref_primary_10_1242_dev_071282
crossref_primary_10_1128_MCB_00354_10
crossref_primary_10_1038_emboj_2011_285
crossref_primary_10_1038_nrg3623
crossref_primary_10_3389_fneur_2021_663793
crossref_primary_10_1007_s00109_009_0554_0
crossref_primary_10_1038_msb_2012_74
crossref_primary_10_1002_1873_3468_12343
crossref_primary_10_1002_ar_21360
crossref_primary_10_1016_j_bbagrm_2016_08_007
crossref_primary_10_1002_1873_3468_12424
crossref_primary_10_1182_blood_2010_05_283291
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1182/blood-2008-11-191890
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
Chemistry
Biology
Anatomy & Physiology
EISSN 1528-0020
ExternalDocumentID 19339695
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA41456
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/F000499/1
– fundername: Cancer Research UK
– fundername: Medical Research Council
  grantid: MC_U120027516
– fundername: Biotechnology and Biological Sciences Research Council
  grantid: BB/E025129/1
– fundername: NCI NIH HHS
  grantid: R01 CA041456
GroupedDBID ---
-~X
.55
0R~
23N
2WC
34G
39C
4.4
53G
5GY
5RE
5VS
6J9
9M8
AAEDW
AALRI
AAXUO
ABOCM
ACGFO
ACVFH
ADBBV
ADCNI
ADVLN
AENEX
AEUPX
AFFNX
AFOSN
AFPUW
AGCQF
AIGII
AITUG
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
BAWUL
BTFSW
C1A
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EFKBS
EIF
EJD
EX3
F5P
FDB
FRP
GS5
GX1
H13
IH2
K-O
KQ8
L7B
LSO
MJL
N4W
N9A
NPM
OK1
P2P
R.V
RHI
ROL
SJN
THE
TR2
TWZ
W2D
W8F
WH7
WOQ
WOW
X7M
YHG
YKV
7X8
ID FETCH-LOGICAL-c557t-649a9b03b2365ad9409a897b218d686dd774c030f689f3880a83fc973664da462
IEDL.DBID 7X8
ISICitedReferencesCount 95
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000268061700015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1528-0020
IngestDate Mon Sep 29 04:57:28 EDT 2025
Mon Jul 21 05:29:20 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c557t-649a9b03b2365ad9409a897b218d686dd774c030f689f3880a83fc973664da462
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://dx.doi.org/10.1182/blood-2008-11-191890
PMID 19339695
PQID 67466219
PQPubID 23479
ParticipantIDs proquest_miscellaneous_67466219
pubmed_primary_19339695
PublicationCentury 2000
PublicationDate 2009-07-09
PublicationDateYYYYMMDD 2009-07-09
PublicationDate_xml – month: 07
  year: 2009
  text: 2009-07-09
  day: 09
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Blood
PublicationTitleAlternate Blood
PublicationYear 2009
References 19589927 - Blood. 2009 Jul 9;114(2):229-30. doi: 10.1182/blood-2009-04-216903.
References_xml – reference: 19589927 - Blood. 2009 Jul 9;114(2):229-30. doi: 10.1182/blood-2009-04-216903.
SSID ssj0014325
Score 2.3019104
Snippet At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 299
SubjectTerms Animals
Blood Cells - metabolism
Cells, Cultured
Chromatin - genetics
Chromatin - metabolism
Core Binding Factor Alpha 2 Subunit - deficiency
Core Binding Factor Alpha 2 Subunit - genetics
Core Binding Factor Alpha 2 Subunit - metabolism
DNA Methylation
Gene Expression Regulation
Mice
Promoter Regions, Genetic - genetics
Protein Binding
RNA, Messenger - genetics
Time Factors
Title Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program
URI https://www.ncbi.nlm.nih.gov/pubmed/19339695
https://www.proquest.com/docview/67466219
Volume 114
WOSCitedRecordID wos000268061700015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9RADLUKhcKFj20LLQV8QNxGzW6SSVwhoVK14kBXFaJob6uZyUSt1E22u11E_xS_sfZMIk6oBy5RLlGi8Yvnjf1sA3zwDAM_rHLly8KoLKdEEQNFpVll6so7W4cpET-_FeNxOZnQ2Rp86mthRFbZ-8TgqKvWSYx8XxeZ1vx7fZ5fK5kZJbnVboDGA1hPmcgIpovJ3xxCloaRq7xBlUpYUVc4x4R6P4rCQ-pfFF00LCn5N8UMW83J8__7yBfwrKOYeBgx8RLWfDOAzcOGj9ezW_yIQfQZoukDePylv3ty1I9-G8DGaZdx34Q_oQMyuotFK9y2wRUjMiSs0N7i9_PxZHiABmf9lF30v-dXJoYYkQkx9hNY2JNc4cKL8DhEJJcYKyRRaj1FrxQfEZXIaokzI30spBmIx7ZGZqkYusu28_ZSyi6Rce_lXVHG22CnM9uC85PjH0dfVTfjQbk8L26UzsiQTVI7SnVuKuLjpimpsMw8Kl3qqmJ66tgR1bqkWhrXmDKtHRWp1oymTI-24WHTNv41oOGFT5y0D2KAjawlpz3b3RBZm2fe78D73mhTXk9JjJjGt6vltDfbDryKdp_OY6uPKdPblDTlu_c--waexkRToRLag_WavYd_C4_cr5vL5eJdgCZfx2end0hA8gk
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+chromatin+unfolding+by+RUNX1%3A+a+molecular+explanation+for+differential+requirements+during+specification+versus+maintenance+of+the+hematopoietic+gene+expression+program&rft.jtitle=Blood&rft.au=Hoogenkamp%2C+Maarten&rft.au=Lichtinger%2C+Monika&rft.au=Krysinska%2C+Hanna&rft.au=Lancrin%2C+Christophe&rft.date=2009-07-09&rft.issn=1528-0020&rft.eissn=1528-0020&rft.volume=114&rft.issue=2&rft.spage=299&rft_id=info:doi/10.1182%2Fblood-2008-11-191890&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-0020&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-0020&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-0020&client=summon